Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
Mating preferences of selfish sex chromosomes.
Clinical evidence of inflammation driving secondary brain injury: a systematic review.
A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (49)
More Search Options
Match
Type
Why
CTLA-4 Antigen
Concept
Why?
Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of symptomatic human cytomegalovirus infection after renal transplantation.
Academic Article
Why?
Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade.
Academic Article
Why?
B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
Academic Article
Why?
Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
Academic Article
Why?
Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
Academic Article
Why?
Association of functional genetic variants of CTLA4 with reduced serum CTLA4 protein levels and increased risk of idiopathic recurrent miscarriages.
Academic Article
Why?
Autoimmunity-mediated antitumor immunity: tumor as an immunoprivileged self.
Academic Article
Why?
Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.
Academic Article
Why?
CTLA4 blockade broadens the peripheral T-cell receptor repertoire.
Academic Article
Why?
Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection.
Academic Article
Why?
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--letter.
Academic Article
Why?
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--response.
Academic Article
Why?
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
Academic Article
Why?
IMMUNOTHERAPY. Could microbial therapy boost cancer immunotherapy?
Academic Article
Why?
Per Page
15
25
50
100
Page
of 4
Next
Prev
Search Criteria
CTLA 4 Antigen
Filter by Type
All
(173)
People
(49)
Research
(123)
Concepts
(1)
_
Click "Why?" to see why an item matched the search.